# Processa Pharmaceuticals, Inc.: Form DEF 14A, filed May 1, 2023

- Company: [Processa Pharmaceuticals, Inc.](/companies/pcsa.md) (CIK 1533743)
- Form: DEF 14A
- Filed: 2023-05-01
- Accepted by EDGAR: May 1, 2023, 10:00 ET
- Period: 2023-05-01
- Accession: 0001493152-23-014884
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1533743/000149315223014884/formdef14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1533743/000149315223014884/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1533743/000149315223014884/formdef14a.htm

Filed May 1, 2023.
Source: SEC EDGAR, the filing index for accession 0001493152-23-014884. Last ingested by Listed: Nov 14, 2026, 23:30 ET. No prices; not investment advice.
